Gastric carcinoma, colon carcinoma Cancer Gastric carcinoma
Conditions
Interventions
Treatment Arm A (WAVE ultrasound dissector):
The operation is performed as described in the surgical report. The WAVE ultrasound dissector is exclusively used for dissection and coagulation.
Treatme
Sponsors
Ethicon Endo-Surgery (Europe) GmbH
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Gastric carcinoma, colon carcinoma 2. Patient's written declaration of informed consent after being given written and oral information 3. General status: operable according to American Society of Anaesthesiologists (ASA) categorisation of the risks of anaesthetic 4. Age over 18, either sex
Exclusion criteria
Exclusion criteria: 1. Enrolment in other clinical trials that might interfere with the present study 2. Refusal of consent to the storage and communication of anonymised medical history data, previous psychiatric illness or other circumstances that might compromise the patient's co-operation Exclusion of patients after enrolment in the trial: 1. Inoperability during the procedure; change of planned procedure 2. Wthdrawal of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of operation time for total gastrectomy/colon resection with WAVE ultrasound dissector. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Reduction of intra-operative blood loss 2. Reduction of the quantity of drainage secretion and dwell time of the drain 3. Comparison of oncological (surgical margins) and functional outcomes between the different methods | — |
Countries
Austria, Germany, Hungary, Italy
Outcome results
None listed